共 50 条
Metabolites study on 5-O-methylvisammioside in vivo and in vitro by ultra high performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry
被引:8
|作者:
Fan, Xueyan
[1
]
Liu, Xiaochen
[1
]
Meng, Caifeng
[1
]
Liu, Ruina
[1
]
Zhang, Zijian
[2
]
Wang, Chunying
[1
]
机构:
[1] Hebei Med Univ, Sch Pharm, Dept Pharmaceut Anal, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Prov Hosp Tradit Chinese Med, Dept Stomatol, Shijiazhuang, Hebei, Peoples R China
关键词:
5-O-methylvisammioside;
mass spectrometry;
metabolites;
traditional Chinese medicine;
ultra high performance liquid chromatography;
FILTER DATA-ACQUISITION;
TRIPLE-TOF-MS/MS;
RADIX-SAPOSHNIKOVIAE;
LIVER-MICROSOMES;
SINGLE RUN;
IDENTIFICATION;
CHROMONES;
ORIDONIN;
ARRAY;
RATS;
D O I:
10.1002/jssc.201900001
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
5-O-Methylvisammioside is one of major chromones of Radix Saposhnikoviae possessing definite pharmacological activities, but there are few reports with respect to the metabolism of 5-O-methylvisammioside. In this work, metabolites in vivo were explored in male Sprague-Dawley rats and in vitro investigated on rat intestinal bacteria incubation model and were identified by using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. An online data acquisition method based on a multiple mass defect filter and dynamic background subtraction was developed to trace all probable metabolites. As a result, 26 metabolites in vivo (including 18, 15, 10, and 10 in rat urine, faece, bile, and blood) and 7 metabolites in vitro were characterized, respectively. Additionally, the main metabolic pathways in vivo and in vitro, including deglycosylation, deglycosylation + demethylation, deglycosylation + oxidation, N-acetylation, and sulfate conjugation, were summarized by calculating the relative content of each metabolite. The obtained results significantly enriched our knowledge about 5-O-methylvisammioside metabolism and will lead to a better understanding of its safety and efficacy.
引用
收藏
页码:2107 / 2114
页数:8
相关论文